Precisely targeting the interface between
innate and adaptive immunity.

David T. Hung, M.D.
President and CEO, Medivation Inc.

Dr. Hung co-founded Medivation (NASDAQ: MDVN) in 2003 and is Medivation’s President and Chief Executive Officer, and a member of its Board of Directors.  From 1998 until 2001, Dr. Hung served as Chief Scientific Officer (1998-1999) and as President, Chief Executive Officer and Director (1999-2001) of ProDuct Health, Inc., a privately-held medical device company.  ProDuct Health, Inc. was acquired in 2001 by Cytyc Corporation for $167 million, after having spent only approximately $22 million in total development costs.  From 1995-1998, Dr. Hung served in various senior positions at Chiron Corporation, a public biotechnology company, with his last position being Vice President of Lead Discovery and Development and Vice President of New Projects.  Dr. Hung received an M.D. Alpha Omega Alpha from the University of California, San Francisco, School of Medicine, and an A.B. summa cum laude in Biology from Harvard College.